Back to ELVN
Vestal Point Capital, LP → ELVN
Vestal Point Capital, LP ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$147.8M
Q3 2026
Peak value
$203M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $59M |
| Q1 2026 | $127.4M |
| Q2 2026 | $203M |
| Q3 2026 | $147.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $147.8M | 3.23M | — | — |
| Q2 2026 | $203M | 4.00M | — | — |
| Q1 2026 | $127.4M | 3.25M | — | — |
| Q4 2025 | $59M | 3.83M | — | — |
Other funds holding ELVN
$449.6M
$394.2M
$343.9M
$326.4M
$312M
$310.6M
$294.5M
$261.1M